We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Scarless Brain Surgery Removes Tumors via Natural Skull Opening

By HospiMedica International staff writers
Posted on 08 Nov 2011
A novel endoscopic transvestibular paramandibular approach uses the infratemporal fossa (ITF) and parapharyngeal space (PPS) to gain access to the middle cranial base.

Researchers at the Johns Hopkins University (JHU) School of Medicine (Baltimore, MD, USA) developed the transvestibular endoscopic approach using a vertical oral mucosal incision along the ascending ramus of the mandible, opening an optical corridor to the ITF and PPS, which was maintained patent with the aid of a Hardy speculum. More...
The contents of the ITF and PPS were then explored with the aid of a 0-degree 4-mm rigid endoscope. The approach was thus able to provide exposure and access to the middle cranial base at the level of the foramen ovale, accessing the mid-PPS.

The new approach was applied to four patients with lesions involving the ITF and PPS, allowing branches of the trigeminal nerve in the ITF to be safely explored and preserved. Exposure and visualization of the internal maxillary artery and branches were also achieved. Of the four patients, two underwent resection of a primary and a recurrent pleomorphic adenoma, one had chronic pain relief from a large synovial chondromatosis, and one had debulking of a recurrent mucoepidermoid carcinoma. The only complications were self-limiting hypoesthesia of the lip in one patient and transient dysphagia in another patient. The study was published in the October 2011 issue of Laryngoscope.

“I looked at the ‘window’ that already exists in the skull, above the jawbone and below the cheekbone and realized this was an access route not previously recognized for this kind of surgery,” said lead author assistant professor of facial plastic and reconstructive surgery Kofi Boahene, MD. “We plan to try the new procedure using a surgical robot, which could provide even better visualization for surgeons and further reduce chances of complications for patients.”

Traditional surgeries to remove skull base tumors require incisions through the face and bone removal, which can sometimes be disfiguring. Additionally, these operations can harm facial nerves, leading to paralysis that affects facial expressions and days or weeks of hospitalization and recovery.

Related Links:

Johns Hopkins University (JHU) School of Medicine



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.